SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-000728
Filing Date
2022-04-11
Accepted
2022-04-11 06:03:27
Documents
90
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q lxrp_10q.htm   iXBRL 10-Q 997690
2 EX-31.1 lxrp_ex311.htm EX-31.1 12245
3 EX-31.2 lxrp_ex312.htm EX-31.2 12312
4 EX-32.1 lxrp_ex321.htm EX-32.1 4886
5 EX-32.2 lxrp_ex322.htm EX-32.2 6063
11 lxrp_10qimg510.jpg GRAPHIC 1582
  Complete submission text file 0001640334-22-000728.txt   5184186

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20220228.xsd EX-101.SCH 57610
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20220228_lab.xml EX-101.LAB 289944
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20220228_cal.xml EX-101.CAL 50736
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20220228_pre.xml EX-101.PRE 244560
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20220228_def.xml EX-101.DEF 110241
84 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10q_htm.xml XML 972498
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 001-39874 | Film No.: 22818407
SIC: 2834 Pharmaceutical Preparations